BioSpace News Archive

Bright Health, an insurance company that provides exclusive Care Partner Health Plans for everyday individuals at competitive prices, today announced it has raised $200 million in an oversubscribed Series C funding round.

Cantel Medical Corp. (NYSE: CMD) today announced financial results for its first quarter ended October 31, 2018.

Released today, a report titled Respected: Perspectives of Youth on High School & Social and Emotional Learning, shows that more than three-quarters (77 percent) of recent high school students believe their schools could have done a better job of helping students develop key social and emotional learning (SEL) skills

Published Results Underscore Value of Oncotype DX® Test in Identifying Women with Early-stage Breast Cancer Who May Receive Life-saving Benefit from Chemotherapy

Alnylam Pharmaceuticals, Inc. announced today that it will webcast its upcoming R&D Day, including a live video stream, on the Investors section of the Company’s website, www.alnylam.com, on the morning of December 6, 2018.

Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company focused on the design, development and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions for the treatment of urinary and bowel dysfunction, announced today that the Axonics r-SNM™ System has been listed on the U.K.’s National Health Service Supply Chain (“NHS SC”) online catalogue,

LAXCO™ Inc. today is pleased to announce its Innovative Technology contract with Vizient, Inc., the largest member-driven health care performance improvement company in the country.

Linear Health Sciences today announced that it has entered into an exclusive distribution agreement with Alliance Medical, a leading distributor for emerging medical technologies, for the Orchid Safety Release Valve™, a patient safety device designed to help prevent intravenous (IV) catheter dislodgement.

Syngenta a member of the Alliance of CEO Climate Leaders Alliance calls for World Leaders to be bold in addressing climate change Improved agriculture technology and practices can play a key role

Johnson & Johnson Medical Devices Companies* announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has enrolled and treated the first patient in its STELLAR** U.S. Investigational Device Exemption (IDE) study.